MedPath

Ultraxime

Brand Name: Ultraxime

Generic Name: Cefixime

Active
Registration Number

DR-XY23851

Dosage Form

Granules For Suspension (Drops)

Issuance Date

January 31, 2023

Expiry Date

February 11, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength20 mg/mL
Packaging10 mL Amber Glass bottle with Medicine Dropper (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Cephalosporin)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

CefiximeActive
Monograph: Cefixime

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform